title: Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid.
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA charles.wells@otsuka-us.com.
authors.forename: Charles D
authors.initials: CD
authors.lastname: Wells
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA.
authors.forename: Rajesh
authors.initials: R
authors.lastname: Gupta
authors.affiliation: Otsuka Novel Products, Munich, Germany.
authors.forename: Norbert
authors.initials: N
authors.lastname: Hittel
authors.affiliation: Otsuka Pharmaceutical Development and Commercialization, Rockville, MD, USA.
authors.forename: Lawrence J
authors.initials: LJ
authors.lastname: Geiter
mesh_terms: D015415:Biomarkers; D005500:Follow-Up Studies; D006801:Humans; D009169:Mycobacterium tuberculosis; D009593:Nitroimidazoles / Q000627:therapeutic use*; D010080:Oxazoles / Q000627:therapeutic use*; D011446:Prospective Studies; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D015415:Biomarkers; D009593:Nitroimidazoles; C516022:OPC-67683; D010080:Oxazoles